From tryptamine to the discovery of efficient multi-target directed ligands against cholinesterase-associated neurodegenerative disorders
A novel class of benzyl-free and benzyl-substituted carbamylated tryptamine derivatives (CDTs) was designed and synthesized to serve as effective building blocks for the development of novel multi-target directed ligands (MTDLs) for the treatment of neurological disorders linked to cholinesterase (C...
Saved in:
Main Authors: | Junbo Wu (Author), Honghua Zhang (Author), Yuying Wang (Author), Gaofeng Yin (Author), Qien Li (Author), Linsheng Zhuo (Author), Hongjin Chen (Author), Zhen Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor
by: Shouyuan Sun, et al.
Published: (2022) -
Novel N-phenyl-2-(aniline) benzamide hydrochloride salt development for colon cancer therapy
by: Yan Peng, et al.
Published: (2024) -
Discovery of Novel Tryptanthrin Derivatives with Benzenesulfonamide Substituents as Multi-Target-Directed Ligands for the Treatment of Alzheimer's Disease
by: Guoxing Wang, et al.
Published: (2023) -
8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases
by: Damijan Knez, et al.
Published: (2023) -
Tryptamine Attenuates Experimental Multiple Sclerosis Through Activation of Aryl Hydrocarbon Receptor
by: Nicholas Dopkins, et al.
Published: (2021)